Comparison 30. PERPHENAZINE vs TRIFLUOPROMAZINE.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Leaving the study early: 1. Any reason	3	178	Risk Ratio (M‐H, Random, 95% CI)	1.14 [0.66, 1.98]
1.1 short term	3	178	Risk Ratio (M‐H, Random, 95% CI)	1.14 [0.66, 1.98]
2 Leaving the study early: 2. Due to adverse events	2	168	Risk Ratio (M‐H, Random, 95% CI)	2.00 [0.74, 5.39]
2.1 short term	2	168	Risk Ratio (M‐H, Random, 95% CI)	2.00 [0.74, 5.39]
3 Global state: 1. Change over time ‐ no better or deterioration (ITT)	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
3.1 short term	1	62	Risk Ratio (M‐H, Random, 95% CI)	0.71 [0.25, 2.01]
4 Adverse events: Movement disorders	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
4.1 akathisia ‐ short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	7.0 [0.89, 54.94]
4.2 akinesia ‐ short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
4.3 dyskinesia ‐ short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	5.0 [0.25, 101.73]
4.4 parkinsonism ‐ short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	17.0 [1.01, 287.24]
5 Other adverse events: 1. Central nervous system	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
5.1 electroencephalogram (increase) ‐ short term	1	10	Risk Ratio (M‐H, Random, 95% CI)	1.0 [0.08, 11.93]